Sanjay Jain
About
In The Last Decade
Sanjay Jain
438 papers receiving 13.7k citations
Peers
Comparison fields: 5 of 193
- Pharmaceutical Science 3.8k
- Molecular Biology 3.4k
- Biomaterials 2.5k
- Pulmonary and Respiratory Medicine 1.7k
- Food Science 1.3k
Countries citing papers authored by Sanjay Jain
This map shows the geographic impact of Sanjay Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjay Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjay Jain more than expected).
Fields of papers citing papers by Sanjay Jain
This network shows the impact of papers produced by Sanjay Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjay Jain. The network helps show where Sanjay Jain may publish in the future.
Co-authorship network of co-authors of Sanjay Jain
This figure shows the co-authorship network connecting the top 25 collaborators of Sanjay Jain. A scholar is included among the top collaborators of Sanjay Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjay Jain. Sanjay Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | Investigations and CAPA: Quality system for continual improvement in pharmaceutical industry | 2 |
| 9 | 5 | |
| 10 | APPROACHES FOR ENHANCING THE BIOAVAILABILITY OF ACYCLOVIR: A CRITICAL REVIEW | 4 |
| 11 | PLGA Nanoparticles for Delivery of Losartan Potassium throughIntranasal Route: Development and Characterization | 2 |
| 12 | Clinico-mycological evaluation of dermatophytes and non-dermatophytes isolated from various clinical samples: A study from north India | 10 |
| 13 | 108 | |
| 14 | 1 | |
| 15 | Extensive arterial and venous thrombosis in a patient with ulcerative colitis--a case report. | 13 |
| 16 | Studies On The Immunomodulatory Effects Of Cleome Viscosa | 14 |
| 17 | Posterior scleritis presenting as unilateral secondary angle-closure glaucoma. | 7 |
| 18 | Formulation Development Studies Of Rofecoxib | 2 |
| 19 | Synthesis carbon 13 nmr and hypotensive action of 2 3 dihydro 2 2 dimethyl 4h naphtho 1 2 b pyran 4 one | 57 |
| 20 | Minor alkaloids of cocculus pendulus | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.